MHB036C

DRUG2 trials

Sponsors

Minghui Pharmaceutical Pty Ltd, Minghui Pharmaceutical (Hangzhou) Ltd

Conditions

Advanced Solid Tumor

Phase 1

Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors

Not yet recruitingNCT05642949

Minghui Pharmaceutical Pty LtdAdvanced Solid Tumor

Start: 2023-01-23End: 2026-06-30Target: 400Updated: 2023-01-09

A Study of MHB036C for Advanced Solid Tumor

Active, not recruitingNCT06373406

Minghui Pharmaceutical (Hangzhou) LtdAdvanced Solid Tumor

Start: 2023-05-26End: 2026-12-31Target: 200Updated: 2025-11-19